Promoting exogenous repair in multiple sclerosis: myelin regeneration
Purpose of the review
Despite the significant progress in the development of disease-modifying treatments for multiple sclerosis (MS), repair of existing damage is still poorly addressed. Current research focuses on stem cell-based therapies as a suitable alternative or complement to current drug therapies.
Recent findings
Myelin damage is a hallmark of multiple sclerosis, and novel approaches leading to remyelination represent a promising tool to prevent neurodegeneration of the underlying axon. With increasing evidence of diminishing remyelination capacity of the MS brain with ageing and disease progression, exogenous cell transplantation is a promising therapeutic approach for restoration of oligodendrocyte precursor cell pool reserve and myelin regeneration.
Summary
The present review summarizes recent developments of remyelinating therapies in multiple sclerosis, focusing on exogenous cell-based strategies and discussing related scientific, practical, and ethical concerns.
Source: Current Opinion in Neurology - Category: Neurology Tags: MULTIPLE SCLEROSIS: Edited by Hans-Peter Hartung Source Type: research
More News: Brain | Gastroschisis Repair | Medical Ethics | Multiple Sclerosis | Neurology | Neuroscience | Stem Cell Therapy | Stem Cells | Transplants